[1]JI R, DOU KF, XU H.Prevention and mangement of recurrence metastasis of hepatocellular carcinoma after liver transplantation[J].J Clin Hepatol, 2014, 30 (1) :7-10. (in Chinese) 季茹, 窦科峰, 许辉.肝细胞癌患者肝移植术后肿瘤复发转移的防治[J].临床肝胆病杂志, 2014, 30 (1) :7-10.
|
[2]JIAO ZY, YU ZY.Surgical treatment of primary liver cancer:progress and prospects[J/CD].Chin J Hepatic Surg:Electronic Edition, 2016, 5 (5) :281-284. (in Chinese) 焦作义, 俞泽元.原发性肝癌外科治疗进展[J/CD].中华肝脏外科手术学电子杂志, 2016, 5 (5) :281-284.
|
[3]AYUB A, ASHFAQ UA, HAQUE A.HBV induced HCC:major risk factors from genetic to molecular level[J].Biomed Res Int, 2013, 2013:810461.
|
[4]SUN B, KARIN M.Obesity, inflammation, and liver cancer[J].J Hepatol, 2012, 56 (3) :704-713.
|
[5]RIDNOUR LA, CHENG RY, SWITZER CH, et al.Molecular pathways:toll-like receptors in the tumor microenvironment——poor prognosis or new therapeutic opportunity[J].Clin Cancer Res, 2013, 19 (6) :1340-1346.
|
[6]MIZUTANI G, NAKANISHI Y, WATANABE N, et al.Expression of somatostatin receptor (SSTR) subtypes (SSTR-1, 2A, 3, 4and 5) in neuroendocrine tumors using real-time RT-PCR Method and immunohistochemistry[J].Acta Histochem Cytochem, 2012, 45 (3) :167-176.
|
[7]WANG L, TANG K, ZHANG Q, et al.Somatostatin receptorbased molecular imaging and therapy for neuroendocrine tumors[J].Biomed Res Int, 2013, 2013 (6) :102819.
|
[8]PENG Y, DENG L, DING Y, et al.Comparative study of somatostatin-human serum albumin fusion proteins and natural somatostatin on receptor binding, internalization and activation[J].PLo S One, 2014, 9 (2) :e89932.
|
[9]SUNL C, COY DH.Somatostatin receptor-targeted anti-cancer therapy[J].Curr Drug Deliv, 2011, 8 (1) :2-10.
|
[10]HU CY, YI CQ.Effect of Human SSTR 3 gene on growth of gastric cancer cells[J].Chin J Clin Gastroenterol, 2005, 17 (6) :282-285. (in Chinese) 呼闯营, 易粹琼.生长抑素受体SSTR 3基因对胃癌细胞生长的影响[J].临床消化病杂志, 2005, 17 (6) :282-285.
|
[11]LEQUOY M, DESBOIS-MOUTHON C, WENDUM D, et al.Somatostatin receptors in resected hepatocellular carcinoma:status and correlation with markers of poor prognosis[J].Histopathology, 2017, 70 (3) :492-498.
|
[12]ABDEL-RAHMAN O, LAMARCA A, VALLE JW, et al.Somatostatin receptor expression in hepatocellular carcinoma:prognostic and therapeutic considerations[J].Endocr Relat Cancer, 2014, 21 (6) :r485-r493.
|
[13]ZHAO WC, ZHANG HB, YANG N, et al.Preoperative predictors of short-term survival after hepatectomy for multinodular hepatocellular carcinoma[J].World J Gastroenterol, 2012, 18 (25) :3272-3281.
|
[14]TWAIJ A, PUCHER PH, SODERGREN MH, et al.Laparoscopic vs open approach to resection of hepatocellular carcinoma in patients with known cirrhosis:systematic review and meta-analysis[J].World J Gastroenterol, 2014, 20 (25) :8274-8281.
|
[15]ZHAO ZY, XI QY, ZHANG YL.Physiological function and kinetic characteristics of somatostatin receptors[J].Chin J Biochem Mol Biol, 2010, 26 (6) :517-522. (in Chinese) 赵增阳, 习欠云, 张永亮.生长抑素受体的生理功能及动力学特征[J].中国生物化学与分子生物学报, 2010, 26 (6) :517-522.
|
[16]LIU Y, JIANG L, MU L.Somatostatin receptor subtypes 2 and 5 are associated with better survival in operable hepatitis B-related hepatocellular carcinoma following octreotide long-acting release treatment[J].Oncol Lett, 2013, 6 (3) :821-828.
|
[1] | Decai KONG, Xiaojing ZHANG, Yangguang YUN, Haoyu DUAN, Junfeng YE. Risk factors for biliary stricture and prognosis after orthotopic liver transplantation[J]. Journal of Clinical Hepatology, 2024, 40(11): 2253-2259. doi: 10.12449/JCH241119 |
[2] | Bingbing ZHU, Jinxiang YANG, Qun ZHANG, Fangyuan GAO, Xianbo WANG. Risk factors for the 90-day prognosis of patients with type I hepatorenal syndrome and establishment of a predictive model[J]. Journal of Clinical Hepatology, 2022, 38(7): 1561-1565. doi: 10.3969/j.issn.1001-5256.2022.07.019 |
[3] | Wanshu LIU, Lijun SHEN, Qinghui ZHAI, Shaojie XIN, Shaoli YOU. Risk factors for acute variceal bleeding in acute-on-chronic liver failure and its influence on prognosis[J]. Journal of Clinical Hepatology, 2022, 38(11): 2532-2536. doi: 10.3969/j.issn.1001-5256.2022.11.018 |
[4] | Siqin LIU, Xiaomei WANG, Xia LI, Luwen LIANG, Ke WANG, Rui WANG. Covert hepatic encephalopathy in liver cirrhosis: Risk factors and prognosis[J]. Journal of Clinical Hepatology, 2022, 38(2): 359-364. doi: 10.3969/j.issn.1001-5256.2022.02.020 |
[5] | Ren DanDan, Liu Na, Zhou LuLu, Zhang Nan, Li ChunXia, Dong Bing, Xu GuangHua. Risk factors for hepatitis B virus-related hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2020, 36(7): 1634-1638. doi: 10.3969/j.issn.1001-5256.2020.07.041 |
[6] | Zhang DaLi, Feng DanNi, Zhang LiJuan, Tang RuJia, He Xi, Zhou Xia, Gao YinJie, Liu ZhenWen, Liu HongLing. Risk factors for recurrence after liver transplantation in patients with hepatocellular carcinoma and their prognosis[J]. Journal of Clinical Hepatology, 2020, 36(9): 1985-1989. doi: 10.3969/j.issn.1001-5256.2020.09.015 |
[7] | Bai Xue, Ma ZuoHong, Hao ZhiQiang, Fu XiBo, Jiao Ao, Shang Hai, Hua XiangDong. Research advances in the risk factors for microvascular invasion in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2019, 35(11): 2578-2581. doi: 10.3969/j.issn.1001-5256.2019.11.042 |
[8] | Zang YouYa, Long PeiYun, Han ZhiWei, Wang Huan, Ruan JingSheng, Huang Shan, Wu GuoBin, Chen Chuang. Establishment and verification of a nomogram for predicting patient prognosis after hepatectomy for hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2019, 35(10): 2225-2230. doi: 10.3969/j.issn.1001-5256.2019.10.019 |
[9] | Hu YueLei, Sun DaWei, Luo FeiXiang, Liu Huan, Lu: GuoYue. Influencing factors for microvascular invasion in patients with single hepatocellular carcinoma and their prognosis[J]. Journal of Clinical Hepatology, 2018, 34(9): 1911-1916. doi: 10.3969/j.issn.1001-5256.2018.09.017 |
[10] | Lu DongLing, Zhu YuPing, Ou Jie, Mao SuFei, Wu GuoBin, He JianBo, Huang Shan, Chen Chuang. Clinical effects of different treatment regimens for Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma and influencing factors for prognosis[J]. Journal of Clinical Hepatology, 2018, 34(9): 1905-1910. doi: 10.3969/j.issn.1001-5256.2018.09.016 |
[11] | Xing ZhiXiang, Shen ShiQiang, Qin Feng, Yang Qiang, Ye Zi. Effect of postoperative adjuvant transarterial chemoembolization on postoperative survival of patients with liver cancer and related influencing factors for prognosis[J]. Journal of Clinical Hepatology, 2017, 33(12): 2331-2336. doi: 10.3969/j.issn.1001-5256.2017.12.015 |
[12] | Li Ying, Zhan Jing, Wang ZhongFeng. Prognostic factors for patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2017, 33(3): 497-501. doi: 10.3969/j.issn.1001-5256.2017.03.020 |
[13] | Wang FengJiao, Liu MingJiang, Wu RuiHong, Niu JunQi. A multivariate logistic regression analysis of short-term prognosis of patients with hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2017, 33(4): 711-714. doi: 10.3969/j.issn.1001-5256.2017.04.022 |
[14] | Zhang Cheng, Qi XingShun, Bo Ming, Zhao Yan, Wang WeiJuan, Han GuoHong. Prognostic factors for transcatheter arterial chemoembolization in patients with hepatocellular carcinoma complicated by portal vein tumor thrombus[J]. Journal of Clinical Hepatology, 2016, 32(1): 84-87. doi: 10.3969/j.issn.1001-5256.2016.01.014 |
[15] | Shi XinXing, Zhang YanQiong, Zhu Peng, Yan GuoHua, Zhang ZhangJiang, Wang YuMing. Prognostic risk factors in patients with hepatitis B virus- related acute- on- chronic liver failure[J]. Journal of Clinical Hepatology, 2016, 32(4): 700-705. doi: 10.3969/j.issn.1001-5256.2016.04.018 |
[16] | Ma ShiJie, Zou ShaoJing, Luo XiaoLing, Li QianJun, Huang JiaSheng. Prognostic factors for transcatheter arterial chemoembolization in patients with hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2016, 32(1): 80-83. doi: 10.3969/j.issn.1001-5256.2016.01.013 |
[17] | Wu XiaoQing, Wan Hong. Causes of liver failure and impact analysis of prognostic risk factors[J]. Journal of Clinical Hepatology, 2013, 29(4): 294-296+304. |
[18] | Liu HongHong, Fu JunLiang, Fu BaoYun, Zhang Zheng, Xu RuoNan, Luo ShengQiang, Shi Ming, Li YongGang, Wang FuSheng. The pathogenesis and risk factors related to prognosis of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(2): 153-155. |
[19] | Lu: RiYing, Li ShiXiong, Wu JiZhou, Zhu YuJia, Fu ShaoPing. Development of a prognostic factors model for severe hepatitis[J]. Journal of Clinical Hepatology, 2012, 28(10): 789-792. |
[20] | Ding HuiGuo, Gao GuiJu, Chen Tao, Jin Rui. Prognosis of Severe Types of Virous Hepatitis: Study on Mutiple Risk Factors.[J]. Journal of Clinical Hepatology, 2002, 18(5): 297-299. |